WASSON GREGORY D 4
4 · OptimizeRx Corp · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
OptimizeRx Director Gregory Wasson Receives 34,517 RSUs
What Happened Gregory D. Wasson, a director of OptimizeRx Corp (OPRX), was granted 34,517 restricted stock units (RSUs) on June 9, 2026. The grant is reported as an award/acquisition (code A) at a reported price of $0.00 (no cash paid at grant). The RSUs represent a contingent right to receive shares of OptimizeRx common stock upon vesting.
Key Details
- Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (appears timely).
- Transaction type/code: Award/Grant (A).
- Units granted: 34,517 RSUs; reported acquisition price: $0.00.
- Vesting: RSUs vest in full on the earlier of the first anniversary of the grant or the Company’s next annual meeting of shareholders (per footnote).
- Shares owned after transaction: not disclosed in this filing.
- Filing includes a standard legal remark clarifying the filing is not an admission of beneficial ownership.
Context RSUs are a form of equity compensation that convert to actual shares only upon vesting; no shares or cash changed hands at the time of grant. Such director awards are commonly part of routine compensation and do not, by themselves, indicate a buy/sell decision by the insider. If and when the RSUs vest, there may be tax withholding or sales to cover taxes depending on the company’s practices.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-09+34,517→ 91,700 total
Footnotes (1)
- [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of the grant or the date of the Company's next annual meeting of shareholders.